Inova Medical Group Cardiology
Cardiology
Dr. Tina L. Slottow, MD
|
|
Give Review
Tina L. Slottow practices Cardiology. She graduated from University of Michigan Medical School. She received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Tina L. Slottow, MD is a published doctor. She has 34 papers published. The most current publication "Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis." Tina Slottow is registered with Medicare and accepts Medicare payments.
Publications
- Clinical outcomes after implantation of small diameter (=2.5 mm) sirolimus- versus paclitaxel-eluting stents.
- Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.
- Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.
- Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with Acute myocardial infarction undergoing primary angiopla...
- Impact of thrombus aspiration use for the treatment of stent thrombosis on early patient outcomes.
- Prognostic value of the Syntax score in patients undergoing Coronary artery bypass grafting for three-vessel Coronary artery disease.
- Requirement for emergent Coronary artery bypass surgery following percutaneous Coronary intervention in the stent era.
- Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
- Prognostic significance of small troponin I rise after a successful elective percutaneous Coronary intervention of a native artery.
- Racial disparities in outcomes following percutaneous Coronary intervention with drug-eluting stents.
- Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
- Very late stent thrombosis after bare-metal stent implantation: case reports and review of the literature.
- Five-year outcomes of moderate or ambiguous left main Coronary artery disease and the intravascular ultrasound predictors of events.
- Impact of a 600-mg loading dose of clopidogrel on 30-day outcome in unselected patients undergoing percutaneous Coronary intervention.
- Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with Acute coronary syndrome.
- The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous Coronary intervention with drug-eluting stents.
- Bivalirudin with provisional glycoprotein IIb/IIIa inhibitors in patients undergoing primary angioplasty in the setting of cardiogenic shock.
- Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with Coronary artery disease (from the REWARDS Regist...
- Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period.
- Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronar...
- Incidence, predictors, and outcomes of post-percutaneous Coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
- Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus.
- Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the endeavor zotarolimus-eluting Coronary stent.
- Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous Coronary intervention.
- Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous Coronary intervention with drug-eluting stents impact late clinical outcome?
- Angiographic and procedural correlates of stent thrombosis after intraCoronary implantation of drug-eluting stents.
- Impact of in-stent restenosis on death and Myocardial infarction.
- Optical coherence tomographic imaging of a bioabsorbable magnesium stent lost in a porcine Coronary artery.
- Correlates of clinical restenosis following intraCoronary implantation of drug-eluting stents.
- Outcomes of Coronary artery bypass grafting versus percutaneous Coronary intervention with drug-eluting stents for patients with multivessel Coronary artery disease.
- Comparison between sirolimus- and paclitaxel-eluting stents in complex patient and lesions subsets.
- Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis.
- Serial imaging and histology illustrating the degradation of a bioabsorbable magnesium stent in a porcine Coronary artery.
Schools
University Of Michigan Medical School
Beth Israel Deaconess Medical Center
Beth Israel Deaconnesss Med Center
GeorgetownWashington Hospital Center
Massachusetts Institute Of Technology
Procedures Preformed
- Angioplasty With Stent Placement
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Georgetown University Hospital - Washington Hospital Center -
University of Michigan Medical School
Hospital
-
Inova Fairfax Hospital -
Inova Fair Oaks Hospital
Drug Facts
| NPI NUMBER | 1912174905 | |
| NPPES Provider LastName | SLOTTOW | |
| NPPES Provider FirstName | TINA | |
| NPPES Provider ZIPCode | 220314621 | |
| NPPES Provider State | VA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 538.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1912174905 |
| Last Name Of The Provider | SLOTTOW |
| First Name Of The Provider | TINA |
| View All |
Similar Doctors
|
|
Dr. Margaret B. Bell-Fischer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Hallal, MD |
|
|
Dr. Ganesh S. Venkataraman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Albert A. Del Negro, MD |
|
Dr. Nicholas A. Cossa, MD |
|
|
Dr. Marc H. Wish, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Goldman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bryan D. Raybuck, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mariano D. Chutuape, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christine D. Bussey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph M. Kiernan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marjaneh Akbari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarfraz A. Durrani, MD
This Doctor is OpenDoctor Recommended.
|